• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Inspire Veterinary Partners Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Other Events

    6/10/25 3:30:57 PM ET
    $IVP
    Farming/Seeds/Milling
    Consumer Staples
    Get the next $IVP alert in real time by email
    false 0001939365 0001939365 2025-06-05 2025-06-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): June 5, 2025

     

    INSPIRE VETERINARY PARTNERS, INC.

    (Exact name of registrant as specified in its charter)

     

    Nevada   001-41792   85-4359258
    (State or other jurisdiction   (Commission File Number)   (I.R.S. Employer
    of incorporation)       Identification No.)

     

    780 Lynnhaven Parkway, Suite 400
    Virginia Beach, VA
      23452
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: (757) 734-5464

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common stock, par value $0.0001   IVP   Nasdaq Capital Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 2.01 Completion of Acquisition or Disposition of Assets.

     

    Debary Animal Clinic Acquisition

     

    On June 5, 2025, pursuant to an asset purchase agreement, dated April 25, 2025 (the “Asset Purchase Agreement”), by and among Inspire Veterinary Partners, Inc. (the “Company”) and IVP FL Holding Company, LLC (“IVP FL”), a Delaware limited liability company and wholly-owned subsidiary of the Company, Joseph A. Suarez, D.V.M., P.A., a Florida corporation (the “Seller”), and Joseph A. Suarez, DVM (the “Owner” and together with the Seller, the “Seller Parties”) completed the acquisition of the Debary Animal Clinic.

     

    The aggregate purchase consideration for the Debary Animal Clinic was $925,000 plus the assumed liabilities described below, consisting of $832,500 to be paid in cash at the closing of the acquisition plus 54,734 restricted shares of the Company’s Class A common stock (the “Class A Common Stock”), which was equal to the quotient obtained by dividing $925,000 by the official closing price of one share of Class A Common Stock as reported by the Nasdaq Capital Market on the trading date immediately prior to the closing.

     

    Pursuant to the Asset Purchase Agreement, IVP FL acquired substantially all of the assets comprising the veterinary clinic operating under the name “Debary Animal Clinic”, including all equipment and other tangible personal property, inventory, customer deposits, prepaid expenses, permits, licenses, franchises, variances, business contracts and equipment leases, books and records, telephone numbers, yellow pages listings, internet websites, electronic mail addresses (including, without limitation, any and all content therein), and social media sites and accounts, goodwill and intangible assets and other proprietary rights relating to the veterinary clinic. The acquisition excluded certain assets, including certain excess cash, patient and medical records and files to the extent non-transferable by applicable law, personal licenses held by individual veterinary professionals, and other stipulated assts. Also pursuant to the Asset Purchase Agreement, IVP FL assumed liabilities arising from business contracts that may arise after the closing.

     

    The closing of the Debary Animal Clinic acquisition was conditioned on the absence of any new statute, rule, regulation or order prohibiting the transactions and any claim, action, suit, arbitration, inquiry, proceeding, investigation, or legal proceeding seeking to restrain or alter the acquisition, as well as other customary closing conditions. The transaction did not require state or federal regulatory approval. 

     

    The foregoing description of the Asset Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Asset Purchase Agreement, a copy of which is attached as Exhibit 10.1 to this Current Report on Form 8-K and which is incorporated herein by reference.

     

    Debary Animal Clinic Real Estate Acquisition

     

    Also on June 5, 2025, pursuant to a real estate asset purchase agreement, dated April 25, 2025 (the “Real Estate Asset Purchase Agreement”), by and between IVP FL and Suarez Enterprises, LLC a Florida limited liability company (“Suarez Enterprises”), completed the acquisition of certain real estate assets related to the Debary Animal Clinic located at 30 S US Hwy 17-92, Debary, Florida 32713 (Parcel No. 803402010030) and 24 S Charles R Beall Blvd, Debary, Florida 32713 (Parcel No. 803402010040).

     

    Pursuant to the Real Estate Asset Purchase Agreement, IVP FL acquired a fee interest in the real property, all buildings, improvements, structures and fixtures, and all intangible property owned by the Suarez Enterprises in connection with the land or improvements, if any, for an aggregate purchase price of $1,132,000, payable in cash.

     

    The foregoing description of the Real Estate Asset Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Real Estate Asset Purchase Agreement, a copy of which is attached as Exhibit 10.2 to this Current Report on Form 8-K and which is incorporated herein by reference.

     

    1

     

     

    Item 3.02 Unregistered Sales of Equity Securities.

     

    The information contained in Item 2.01 of this Current Report on Form 8-K is incorporated herein by reference into this Item 3.02.

     

    The issuance of restricted shares of Class A Common Stock to the Seller Parties was consummated in privately negotiated transaction exempt from registration pursuant to Rule 506(b) of Regulation D under the Securities Act of 1933, as amended. There were no proceeds from the issuance of the shares of Class A Common Stock.   

     

    Item 8.01. Other Events.

     

    On June 5, 2025, the Company issued a press release announcing the closing of the Debary Animal Clinic acquisition and related real estate assets, a copy of which is attached as Exhibit 99.1to this Current Report on Form 8-K.

     

    Forward-Looking Statements

     

    This press release contains forward-looking statements regarding the Company’s current expectations. These forward-looking statements include, without limitation, references to the Company’s expectations regarding the acquisition of the Debary Animal Clinic and the related real estate assets. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, risks and uncertainties related to the acquisition of the Debary Animal Clinic and the related real estate assets. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law.

     

    Item. 9.01. Financial Statements and Exhibits

     

    Exhibit No.   Description
    10.1   Asset Purchase Acquisition Agreement by and among the Company IVP FL Holding Company, LLC, Joseph A. Suarez, D.V.M., P.A., and Joseph A. Suarez, DVM †
    10.2   Real Estate Asset Purchase Agreement by and among Suarez Enterprises, LLC and IVP FL Properties LLC
    99.1   Press Release dated June 5, 2025
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

     

    2

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: June 10, 2025 INSPIRE VETERINARY PARTNERS, INC.
       
      By: /s/ Kimball Carr
      Name:  Kimball Carr
      Title: President and Chief Executive Officer

     

     

     

    3

     

    Get the next $IVP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $IVP

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $IVP
    Financials

    Live finance-specific insights

    See more
    • Inspire Veterinary Partners Announces Acquisition of Valley Veterinary Service Animal Hospital

      Latest acquisition brings the total number of Inspire locations to 14.Expansion into a new state, Pennsylvania.Pipeline of attractive potential acquisitions of animal hospitals remains active.VIRGINIA BEACH, VA / ACCESSWIRE / November 8, 2023 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced that it has completed the acquisition of Valley Veterinary Service, Inc. animal hospital located in Pennsylvania, Inspire's first entry in that state.Valley Veterinary Service's 2022 gross revenues were in excess of $1.7 million. As part of the transaction, Inspire acquired certain real est

      11/8/23 2:00:00 AM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples

    $IVP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Watters Timothy sold $85 worth of shares (467 units at $0.18), closing all direct ownership in the company (SEC Form 4)

      4 - INSPIRE VETERINARY PARTNERS, INC. (0001939365) (Issuer)

      12/30/24 3:32:49 PM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples
    • Large owner Alomari Ahmed sold $497,640 worth of shares (50,000 units at $9.95), decreasing direct ownership by 33% to 100,000 units (SEC Form 4)

      4 - INSPIRE VETERINARY PARTNERS, INC. (0001939365) (Issuer)

      7/17/24 8:50:08 PM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples
    • New insider Alomari Ahmed claimed ownership of 150,000 shares (SEC Form 3)

      3 - INSPIRE VETERINARY PARTNERS, INC. (0001939365) (Issuer)

      7/17/24 8:49:11 PM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples

    $IVP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Inspire Veterinary Partners Inc.

      SC 13G/A - INSPIRE VETERINARY PARTNERS, INC. (0001939365) (Subject)

      10/11/24 4:05:57 PM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples
    • SEC Form SC 13G filed by Inspire Veterinary Partners Inc.

      SC 13G - INSPIRE VETERINARY PARTNERS, INC. (0001939365) (Subject)

      7/19/24 9:30:47 PM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples

    $IVP
    Leadership Updates

    Live Leadership Updates

    See more
    • Inspire Veterinary Partners Announces Non-Binding Acquisition Proposal of Vetsie.ai

      VIRGINIA BEACH, VA / ACCESSWIRE / August 27, 2024 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced that it has entered into a non-binding letter of intent (the "LOI") with Vetsie.ai, an Artificial Intelligence ("AI") software platform designed to empower veterinary professionals with quick, accurate access to critical information on patient conditions, treatments, and medications, to engage in diligence and initial negotiations regarding the terms of a potential transaction whereby Inspire may Acquire Vetsie.ai in an all- stock transaction. This potential equity-only acquisiti

      8/27/24 8:30:00 AM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples
    • Inspire Veterinary Partners Announces Phillip Balatsos as New Independent Nominee for Election to Board of Directors

      VIRGINIA BEACH, VA / ACCESSWIRE / August 16, 2024 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced that its board of directors has nominated Phillip Balatsos to stand for election as an independent director at its annual meeting of stockholders on October 9, 2024.Mr. Balatsos has served as the Vice President of Foreign Exchange Emerging Markets Rates Sales/Trading with XP Investments US Inc. since August 2022. Mr. Balatsos provides coverage and execution of currency trading in emerging markets as well as commodity and fixed income products and derivatives for global macro hedg

      8/16/24 8:30:00 AM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples

    $IVP
    SEC Filings

    See more
    • Inspire Veterinary Partners Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Other Events

      8-K - INSPIRE VETERINARY PARTNERS, INC. (0001939365) (Filer)

      6/10/25 3:30:57 PM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples
    • Inspire Veterinary Partners Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities

      8-K - INSPIRE VETERINARY PARTNERS, INC. (0001939365) (Filer)

      6/5/25 4:16:45 PM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples
    • SEC Form DEF 14C filed by Inspire Veterinary Partners Inc.

      DEF 14C - INSPIRE VETERINARY PARTNERS, INC. (0001939365) (Filer)

      5/22/25 4:59:39 PM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples

    $IVP
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Inspire Veterinary Partners Reports Third Quarter 2024 Financial Results

      VIRGINIA BEACH, VA / ACCESSWIRE / November 13, 2024 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today reported its financial results for the third quarter and nine months ended September 30, 2024.Select Third Quarter 2024 Highlights Compared to Prior Year PeriodTotal revenue of approximately $4.0 million, a decrease of 1.7%Services revenue of $2.9 million, an increase of 1%Product revenue of $1.1 million, a decrease of 9%G&A decreased 16%Net loss decreased 56%Total revenue of approximately $13.3 million, an increase of 3%Services revenue of approximately $9.7 million, an increase of 6%Pr

      11/13/24 5:56:00 PM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples
    • Spartan Capital Securities Successfully Completes Multiple Key Transactions in October 2024

      NEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Spartan Capital Securities, LLC, a full-service investment banking firm, is proud to announce its successful completion of several notable transactions throughout October 2024. The deals demonstrate Spartan's expertise and unwavering commitment to supporting clients' growth and capital needs across diverse sectors. In October, Spartan Capital Securities served as the placement agent for 1847 Holdings LLC's follow-on offering, raising $11,099,985. This capital infusion will enable 1847 Holdings LLC (NYSE:EFSH), a diversified holding company, to continue its growth strategy, enhance operational flexibility, and pursue acquisition opportunit

      11/1/24 2:36:24 PM ET
      $EFSH
      $IVP
      $TPET
      Professional Services
      Consumer Discretionary
      Farming/Seeds/Milling
      Consumer Staples
    • Spartan Capital Securities, LLC Serves as Sole Placement Agent in Inspire Veterinary Partners' $2.5 Million Registered Direct Offering

      New York, NY, Oct. 28, 2024 (GLOBE NEWSWIRE) --  Spartan Capital Securities, LLC, a leading investment banking firm, is pleased to announce its role as the sole placement agent in Inspire Veterinary Partners, Inc.'s (NASDAQ:IVP) $2.5 million registered direct offering of Class A common stock. Inspire Veterinary Partners, a provider of veterinary healthcare services throughout the U.S., has entered into a securities purchase agreement with institutional investors to sell 10,000,000 shares of Class A common stock at a price of $0.25 per share. The offering is expected to generate gross proceeds of $2.5 million, before deducting placement agent fees and other related expenses. The company pl

      10/28/24 4:36:58 PM ET
      $IVP
      Farming/Seeds/Milling
      Consumer Staples